Advanced lung cancer inflammation index (ALI) association with increased risk of immune related adverse events (irAE) among non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy

V. Bhat, M. Millward, E. S. Gray, A. Abed

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S1575-S1575
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - Nov 2022
EventESMO Asia Congress - Singapore, Singapore
Duration: 2 Dec 20224 Dec 2022

Cite this